Andrew Obenshain - 10 Feb 2025 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
President and CEO, Director
Signature
/s/ Sydney Gaylin, Attorney-in-Fact
Issuer symbol
BLUE
Transactions as of
10 Feb 2025
Net transactions value
$0
Form type
4
Filing time
12 Feb 2025, 16:13:34 UTC
Previous filing
05 Feb 2025
Next filing
05 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Award $0 +763 +4.1% $0.000000 19,248 10 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned from a performance stock unit (PSU) award granted to the Reporting Person on February 1, 2022, based on certain performance conditions. On February 9, 2025, the Compensation Committee of the Board of Directors determined that certain performance conditions have been satisfied.